423 related articles for article (PubMed ID: 16493840)
1. In search of a compromised solution to the problem arising from patenting biomedical research tools.
Derzko NM
Santa Clara Comput High Technol Law J; 2004; 20(2):347-410. PubMed ID: 16493840
[No Abstract] [Full Text] [Related]
2. Science and the law. Working through the patent problem.
Walsh JP; Cohen WM; Arora A
Science; 2003 Feb; 299(5609):1021. PubMed ID: 12586928
[No Abstract] [Full Text] [Related]
3. A modest proposal: toward improved access to biotechnology research tools by implementing a broad experimental use exception.
Hoffman DC
Cornell Law Rev; 2004 May; 89(4):993-1043. PubMed ID: 15174465
[No Abstract] [Full Text] [Related]
4. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp].
Westerlund L
Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544
[No Abstract] [Full Text] [Related]
5. Patenting basic research: myths and realities.
Kirschenbaum SR
Nat Neurosci; 2002 Nov; 5 Suppl():1025-7. PubMed ID: 12403976
[No Abstract] [Full Text] [Related]
6. A guide to drug discovery. Protecting your inventions: the patent system.
Webber PM
Nat Rev Drug Discov; 2003 Oct; 2(10):823-30. PubMed ID: 14526385
[TBL] [Abstract][Full Text] [Related]
7. Research interactions between industry and academia: a corporate perspective.
Citron P
Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116
[No Abstract] [Full Text] [Related]
8. The scope of utility in the twenty-first century: new guidance for gene-related patents.
Summers TM
Georgetown Law J; 2003 Jan; 91(2):475-509. PubMed ID: 15046071
[No Abstract] [Full Text] [Related]
9. Enforcing pharmaceutical and biotech patent rights in China.
Zhang YP; Deng MM
Nat Biotechnol; 2008 Nov; 26(11):1235-40. PubMed ID: 18997760
[No Abstract] [Full Text] [Related]
10. Of mice and men: patenting the oncomouse.
Knowles LP
Hastings Cent Rep; 2003; 33(2):6-7. PubMed ID: 12760110
[No Abstract] [Full Text] [Related]
11. Innovation in biomedicine: can stem cell research lead the way to affordability?
Goozner M
PLoS Med; 2006 Feb; 3(5):e126. PubMed ID: 16492088
[TBL] [Abstract][Full Text] [Related]
12. Ordering life: law and the normalization of biotechnology.
Jasanoff S
Not Polit; 2001; 17(62):34-50. PubMed ID: 15468485
[No Abstract] [Full Text] [Related]
13. University-based science and biotechnology products: defining the boundaries of intellectual property.
Kesselheim AS; Avorn J
JAMA; 2005 Feb; 293(7):850-4. PubMed ID: 15713775
[TBL] [Abstract][Full Text] [Related]
14. Biomedical patents and ethics: a Canadian solution.
Gold ER
McGill Law J; 2000 May; 45(2):413-35. PubMed ID: 12688288
[TBL] [Abstract][Full Text] [Related]
15. Industry and academia in transition.
Kennedy D
Science; 2003 Nov; 302(5649):1293. PubMed ID: 14631000
[No Abstract] [Full Text] [Related]
16. Much ado about gene patents: the role of foreseeability.
Gulliford MJ
Seton Hall Law Rev; 2004; 34(2):711-45. PubMed ID: 15115032
[No Abstract] [Full Text] [Related]
17. Biotechnology products and university-based science.
Lempert P
JAMA; 2005 Jun; 293(23):2861-2; author reply 2863. PubMed ID: 15956627
[No Abstract] [Full Text] [Related]
18. The human use of humanoid beings: chimeras and patent law.
Rabin S
Nat Biotechnol; 2006 May; 24(5):517-9. PubMed ID: 16680130
[TBL] [Abstract][Full Text] [Related]
19. Companies balk at California's patent rules for stem cell research.
Keim B
Nat Med; 2007 Jan; 13(1):6. PubMed ID: 17206112
[No Abstract] [Full Text] [Related]
20. Biomedical research and the commercialization agenda: a review of main considerations for neuroscience.
Caulfield T; Ogbogu U
Account Res; 2008; 15(4):303-20. PubMed ID: 18972268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
